You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

overall toxicity value

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

New Echocardiographic Indicators in Treatment of Primary

Not yet recruiting
  • Multiple Myeloma
  • Chemotherapy and/or autologous hematopoietic stem cell transplantation
  • (no location specified)
Sep 18, 2023

Acute and Chronic Organophosphate Toxicity

Recruiting
  • Neuroinflammatory Response
  • +5 more
  • exposure to organophosphates
  • Alexandria, Egypt
    Alexandria Main University Hospital
Aug 27, 2023

G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity

Active, not recruiting
  • Predicting Chemotherapy Related Toxicity in Elderly Patients
  • Older Patients Receiving Chemotherapy
  • Tekirdağ, Turkey
    Tekirdağ Namık Kemal University
Aug 1, 2021

Radiation Toxicity, Fibrosis, Breast Cancer Trial in Metz, Nancy, Esch-sur-Alzette (Blood sampling)

Not yet recruiting
  • Radiation Toxicity
  • +2 more
  • Blood sampling
  • (no location specified)
Jun 24, 2021

Carcinoma,Non-Small-Cell Lung Trial in Guangzhou (cisplatin and pemetrexed, nedaplatin+pemetrexed)

Recruiting
  • Carcinoma，Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of cancer center
Feb 8, 2022

Older Patients With Breast Cancer

Recruiting
  • Aging
  • +3 more
    • Beijing, Beijing, China
      Peking university people's hospital
    May 27, 2019

    Surufatinib in G3 Neuroendocrine Tumors

    Not yet recruiting
    • Neuroendocrine Tumor Grade 3
    • (no location specified)
    Aug 2, 2023

    Localized Prostate Carcinoma Trial in Milan (prostate SBRT)

    Not yet recruiting
    • Localized Prostate Carcinoma
    • prostate SBRT
    • Milan, MI, Italy
      San Raffaele Scientific Institute
    Jun 29, 2023

    Rectal Tumors Trial in Mumbai (Chlorophyllin, Sodium Copper Complex, Placebo)

    Not yet recruiting
    • Rectal Neoplasms
    • Chlorophyllin, Sodium Copper Complex
    • Placebo
    • Mumbai, Maharashtra, India
      Tata Memorial Hospital
    May 3, 2023

    Metastatic Cancer Trial in London (Arm 2: SABR, Arm 1: Standard of Care)

    Not yet recruiting
    • Metastatic Cancer
    • Arm 2: SABR
    • Arm 1: Standard of Care
    • London, Ontario, Canada
      London Health Sciences Centre- London Regional Cancer Program
    Aug 17, 2022

    Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)

    Not yet recruiting
    • Cancer
    • [177Lu]Lu-PSMA I&T
    • Meldola, Forlì, Italy
    • +1 more
    May 10, 2023

    Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • +2 more
    • standard Radiotherapy
    • +3 more
    • (no location specified)
    Oct 20, 2023

    Cancer, Chemotherapeutic Agent Toxicity Trial in Santiago (Contigo Application)

    Not yet recruiting
    • Cancer
    • Chemotherapeutic Agent Toxicity
    • Contigo Application
    • Santiago, Chile
      Complejo Asistencial Dr. Sotero del Río
    Oct 10, 2023

    Recurrent Pancreatic Ductal Adenocarcinoma Trial in Amsterdam, Rotterdam, Utrecht (Additional stereotactic body radiation

    Enrolling by invitation
    • Recurrent Pancreatic Ductal Adenocarcinoma
    • Additional stereotactic body radiation therapy
    • Amsterdam, Noord-Holland, Netherlands
    • +2 more
    May 17, 2022

    Breast Cancer, Chemo Effect Trial in Beijing (Chidamide)

    Recruiting
    • Breast Cancer
    • Chemotherapy Effect
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Feb 17, 2023

    Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

    Recruiting
    • Pancreatic Cancer
    • Daily Adaptive External Beam Radiation Therapy
    • Saint Louis, Missouri
      Washington University, St. Louis
    Mar 7, 2023

    Progression-free Survival, Overall Survival, Toxicity Trial in Beijing (pegylated liposomal doxorubicin, pirarubicin)

    Withdrawn
    • Progression-free Survival
    • +2 more
    • Beijing, China
      Peking University People's Hospital
    May 15, 2020

    Breast Cancer Radiotherapy Trial in Zagazig (adjuvant radiotherapy)

    Completed
    • Breast Cancer Radiotherapy
    • adjuvant radiotherapy
    • Zagazig, Sharqia, Egypt
      Zagazig university hospitals
    Oct 23, 2022

    Renal Cell Carcinoma Trial (Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 11, 2023

    Cancer, Brain Metastases, Adult Trial in Copenhagen (Repeated stereotactic radiosurgery)

    Recruiting
    • Cancer
    • Brain Metastases, Adult
    • Repeated stereotactic radiosurgery
    • Copenhagen, Denmark
      Rigshospitalet, University of Copenhagen
    Nov 8, 2021

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Sep 20, 2023

    Immunotherapy-related CRP Kinetics in Metastatic Gynecological

    Recruiting
    • Gynecological Malignancies
    • +4 more
      • Tuebingen, Germany
        Department of Women's Health
      Jun 13, 2023

      Metastatic Renal Cell Carcinoma Trial in Italy (Axitinib, Nivolumab)

      Not yet recruiting
      • Metastatic Renal Cell Carcinoma
      • Brescia, Italy
      • +22 more
      Apr 19, 2023

      Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

      Not yet recruiting
      • Breast Cancer
        • (no location specified)
        Jul 18, 2022

        Concurrent Paclitaxel and Radiotherapy After Adjuvant

        Not yet recruiting
        • Breast Cancer
        • Concurrent chemoradiation
        • (no location specified)
        Oct 16, 2022